Estimating Carcinogenic Potency from a Rodent Tumorigenicity Experiment
Dianne M. Finkelstein and
Louise M. Ryan
Journal of the Royal Statistical Society Series C, 1987, vol. 36, issue 2, 121-133
Abstract:
Rodent tumorigenicity experiments are conducted to determine whether a particular substance accelerates tumour development. The association between exposure to this substance and the risk of tumour development can be characterized by a measure of carcinogenic potency. The most commonly used potency measure, the dose effect on the lifetime risk of tumour, may be seriously biased, especially when control and exposed groups differ with respect to longevity. However, more appropriate measures, which account for age at death, are largely unavailable except in the special cases of instantly lethal or nonlethal tumours or tumours with observable onset. In this paper, we propose an estimate of carcinogenic potency based on a proportonal prevalence odds model which applies regardless of tumour lethality and can be calculated using standard statistical methodologies. Furthermore, we show how our estimator can be used to generalize available potency estimators to tumours of any lethality.
Date: 1987
References: Add references at CitEc
Citations: View citations in EconPapers (3)
Downloads: (external link)
https://doi.org/10.2307/2347543
Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.
Export reference: BibTeX
RIS (EndNote, ProCite, RefMan)
HTML/Text
Persistent link: https://EconPapers.repec.org/RePEc:bla:jorssc:v:36:y:1987:i:2:p:121-133
Ordering information: This journal article can be ordered from
http://ordering.onli ... 1111/(ISSN)1467-9876
Access Statistics for this article
Journal of the Royal Statistical Society Series C is currently edited by R. Chandler and P. W. F. Smith
More articles in Journal of the Royal Statistical Society Series C from Royal Statistical Society Contact information at EDIRC.
Bibliographic data for series maintained by Wiley Content Delivery ().